| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them |
| 08/16/2005 | CA2220438C (n-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| 08/16/2005 | CA2106642C Carbazolone derivatives and process for preparing the same |
| 08/16/2005 | CA2094859C Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 08/16/2005 | CA2078221C Pharmaceutical compositions comprising taurolidine and/or taurultam |
| 08/11/2005 | WO2005073220A1 Remedy for irritable bowel syndrome with diarrhea |
| 08/11/2005 | WO2005072763A1 Liver fibrosis inhibitor |
| 08/11/2005 | WO2005072730A1 Therapeutic agent for diarrhea-type irritable bowel syndrome |
| 08/11/2005 | WO2005072690A1 Antimicrobial oral rinse solid composition |
| 08/11/2005 | WO2005039609A3 Moderating the effect of endotoxins |
| 08/11/2005 | WO2004009766A3 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 08/11/2005 | US20050177876 Fcyriia transgenic animal model for autoimmune disease |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176938 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate |
| 08/11/2005 | US20050176933 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis |
| 08/11/2005 | US20050176788 Such as 2-[N-(4,5-dimethoxy-2-hydroxybenzoyl)amino]-4-[(2-diisopropylaminoethyl)aminocarbonyl]-1,3-thiazole; compounds relax gastric fundus, to relieve feeling of early satiety and bloating; gastrointestinal motility disorders |
| 08/11/2005 | US20050176780 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors |
| 08/11/2005 | US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176759 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176746 Treating eating disorders and digestive disorders wth loperamide |
| 08/11/2005 | US20050176745 Based on spiro(1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine) ring; ligands for nicotinic acetylcholine receptors; Alzheimer's disease, cognitive or attention disorders, anxiety, depression, smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's and Parkinson's |
| 08/11/2005 | US20050176739 Xanthine derivatives; adenosine receptor antagonists; anorexia; 8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines |
| 08/11/2005 | US20050176720 Pharmaceutical composition for the treatment of CNS and other disorders |
| 08/11/2005 | US20050176715 Piperidine derivatives |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof |
| 08/11/2005 | US20050176698 Neuropeptide Y antagonists |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176685 Administering bisphosphonate compounds such as ibandronate, minodronate, pamidronate, risedronate, zoledronate, and alendronate; osteoporosis |
| 08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
| 08/11/2005 | US20050176648 oligopeptide including enantiomers, stereoisomers and tautomers, used as hepatitis c protease enzyme inhibitors for prophylaxis or prevention of viral diseases |
| 08/11/2005 | US20050176123 Protease inhibitor |
| 08/11/2005 | US20050175629 Helicobacter pylori vaccination |
| 08/11/2005 | US20050175597 For easy administration and storage stability |
| 08/11/2005 | US20050175550 Trifluoromethionine for preventing and/or treating intraoral diseases; bad breath, periodontal disease, alveolar pyorrhea; bactericide |
| 08/11/2005 | CA2774961A1 Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials |
| 08/11/2005 | CA2554403A1 Gastrointestinal proliferative factor and uses thereof |
| 08/11/2005 | CA2553455A1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis |
| 08/10/2005 | EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 08/10/2005 | EP1561458A1 Rapidly disintegrable solid preparation |
| 08/10/2005 | EP1560816A1 Quinazoline derivatives |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1560578A1 Use of the distrontium salt of the acid 2- n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain |
| 08/10/2005 | EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 08/10/2005 | EP1358187B1 Naphthyridine derivatives |
| 08/10/2005 | EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 08/10/2005 | EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 08/10/2005 | EP1208103B1 Reverse-turn mimetics and methods relating thereto |
| 08/10/2005 | EP1075262B1 Desmethylpantoprazole compositions and methods |
| 08/10/2005 | EP1042359B1 Kappa receptor opioid peptides |
| 08/10/2005 | EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 08/10/2005 | CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 08/10/2005 | CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 08/10/2005 | CN1653083A Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 08/10/2005 | CN1653069A R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease |
| 08/10/2005 | CN1653068A Novel diazabicyclic biaryl derivatives |
| 08/10/2005 | CN1653063A (S)-4-amino-5-chloro-2-methoxy-N-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, and method for producing the same, pharmaceutical composition containing the same and i |
| 08/10/2005 | CN1653059A Macrocyclic compounds useful as pharmaceuticals |
| 08/10/2005 | CN1653054A Benzoxazine derivatives as 5-HT6 modulators and uses thereof |
| 08/10/2005 | CN1653050A Opioid and opioid-like compounds and uses thereof |
| 08/10/2005 | CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 08/10/2005 | CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 08/10/2005 | CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 08/10/2005 | CN1653036A Amino acids with affinity for the alpha-2-delta-protein |
| 08/10/2005 | CN1653025A NK1 antagonists |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/10/2005 | CN1652810A Immunosuppressant compounds, methods and uses related thereto |
| 08/10/2005 | CN1652808A Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 08/10/2005 | CN1652802A Methods of treating necrotizing enterocolitis |
| 08/10/2005 | CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/10/2005 | CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/10/2005 | CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/10/2005 | CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof |
| 08/10/2005 | CN1652771A Annelated pyrrole compounds as proton pump inhibitors for treating ulcer |
| 08/10/2005 | CN1652769A Phosphate prodrugs of fluorooxindoles |
| 08/10/2005 | CN1652764A TGF-alpha expression inhibitors |
| 08/10/2005 | CN1652763A Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
| 08/10/2005 | CN1652758A Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives |
| 08/10/2005 | CN1652698A Method and dietary composition for improving lipid digestibility |
| 08/10/2005 | CN1652697A Method and dietary composition for improving fat digestibility |
| 08/10/2005 | CN1652696A Method of improving absorption of vitamin E by a pet animal |